Who Exports Linezolid from India — 234 Suppliers Behind a $37.5M Market
India's linezolid export market is supplied by 234 active exporters who collectively shipped $37.5M across 1,427 shipments. MACLEODS PHARMACEUTICALS LTD leads with a 25.2% market share, followed by ALKEM LABORATORIES LIMITED and LUPIN LIMITED. The top 5 suppliers together control 68.8% of total export value, reflecting a concentrated market structure.
Top Linezolid Exporters from India — Ranked by Export Value
MACLEODS PHARMACEUTICALS LTD is the leading linezolid exporter from India, holding a 25.2% share of the $37.5M market across 1,427 shipments from 234 exporters. The top 5 suppliers — MACLEODS PHARMACEUTICALS LTD, ALKEM LABORATORIES LIMITED, LUPIN LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, ANNORA PHARMA PRIVATE LIMITED — collectively control 68.8% of total export value, indicating a moderately concentrated market. Individual shares are: MACLEODS PHARMACEUTICALS LTD (25.2%), ALKEM LABORATORIES LIMITED (15.2%), LUPIN LIMITED (10.4%), EUGIA PHARMA SPECIALITIES LIMITED (10.1%), ANNORA PHARMA PRIVATE LIMITED (7.8%).
Top Linezolid Exporters from India
Ranked by export value · 234 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD LINEZOLID 600MG TABLETS.LINEZOLID 600MG TABLETSLINEZOLID ORAL SUSPENSION SOLUTION | $9.4M | 20 | 25.2% |
| 2 | ALKEM LABORATORIES LIMITED LINEZOLID ORAL SUSPENSION SOLUTIONPHARMACEUTICAL PRODUCTS - LINEZOLID TABLETS 600MG USALINEZOLID 600MG TABLETS | $5.7M | 8 | 15.2% |
| 3 | LUPIN LIMITED LINEZOLID TABLETS 600MG GDF 10X10 LINEZOLINEZOLID 600MG TABLETSLINEZOLID TABLETS USP 600MG | $3.9M | 9 | 10.4% |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED LINEZOLID ORAL SUSPENSION SOLUTIONPHARMACEUTICAL PRODUCTS - LINEZOLID TABLETS 600MG USALINEZOLID 600MG TABLETS | $3.8M | 3 | 10.1% |
| 5 | ANNORA PHARMA PRIVATE LIMITED LINEZOLID ORAL SUSPENSION SOLUTIONPHARMACEUTICAL PRODUCTS - LINEZOLID TABLETS 600MG USALINEZOLID 600MG TABLETS | $2.9M | 1 | 7.8% |
| 6 | MACLEODS PHARMACEUTICALS LIMITED LINEZOLID 600MG TABLETS.LINEZOLID 600MG TABLETSLINEZOLID ORAL SUSPENSION SOLUTION | $2.0M | 12 | 5.3% |
| 7 | JODAS EXPOIM PRIVATE LIMITED LINEZOLID TABLETS 600MG ( | $1.5M | 1 | 3.9% |
| 8 | ACULIFE HEALTHCARE PRIVATE LIMITED LINEZOLID I.V. INJECTION # LINESTARLINEZOLID IV INJECTIONLINEZOLID I.V.INJECTION 2MG/ML | $1.5M | 8 | 3.9% |
| 9 | MICRO LABS LIMITED LINEZOLID TABLETS 600MG GDF 10X10 LINEZOLINEZOLID TABLETS USP 600MGLINEZOLID TABLETS 600 MG (10 X 10'S X 47 | $1.4M | 7 | 3.8% |
| 10 | HETERO LABS LIMITED LINEZOLID ORAL SUSPENSION SOLUTIONPHARMACEUTICAL PRODUCTS - LINEZOLID TABLETS 600MG USALINEZOLID 600MG TABLETS | $1.0M | 4 | 2.7% |
| 11 | AHLCON PARENTERALS (INDIA) LIMITED LINEZOLID TABLETS 600 MG (10 X 10'S X 47LINEZOLID TABLETS USP 600MGLINEZOLID IV INJECTION | $540.1K | 4 | 1.4% |
| 12 | INTAS PHARMACEUTICALS LIMITED ELUTRIN 600 BNOELUTRIN 600 LINEZOLID 600MG TABLET BNELTURIN 600 1 X10S BNO:BLN32 | $518.7K | 3 | 1.4% |
| 13 | UNICHEM LABORATORIES LIMITED LINEZOLID 600MG TABLETS. 10X10'S 6665PACKLINEZOLID 600MG TABLETS. (5136LINOX 600MG TABLETS LINEZOLID TABLETS 60 | $416.3K | 1 | 1.1% |
| 14 | AXA PARENTERALS LIMITED LINEZOLID TABLETS 600 MG (10 X 10'S X 47LINEZOLID TABLETS USP 600MGLINEZOLID 600MG TABLETS. 10X10'S 8596PACK | $325.8K | 5 | 0.9% |
| 15 | DR.REDDY'S LABORATORIES LIMITED | $220.5K | 1 | 0.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Linezolid exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Macleods Pharmaceuticals Limited | Approved | Yes, as of June 2023 | Yes | Multiple | FDA-approved with multiple ANDAs; WHO-GMP certified as of June 2023; holds EU GM |
| Alkem Laboratories Limited | Approved | Yes | Yes | Multiple | FDA-approved with multiple ANDAs; WHO-GMP and EU GMP certified. |
| Lupin Limited | Approved | Yes | Yes | Multiple | FDA-approved with multiple ANDAs; WHO-GMP and EU GMP certified. |
| Micro Labs Limited | Approved | Yes, as of December | Yes | Multiple | FDA-approved with multiple ANDAs; WHO-GMP certified as of December 2022; holds E |
| Hetero Labs Limited | Approved | Yes | Yes | Multiple | FDA-approved with multiple ANDAs; WHO-GMP and EU GMP certified. |
| Unichem Laboratories Limited | Approved | Yes | Yes | Multiple | FDA-approved with multiple ANDAs; WHO-GMP and EU GMP certified. |
| Dr. Reddy's Laboratories Limited | Approved | Yes | Yes | Multiple | FDA-approved with multiple ANDAs; WHO-GMP and EU GMP certified. |
TransData Nexus reviewed the regulatory standing of 7 leading Linezolid exporters from India. 7 hold US FDA facility approvals, 7 maintain WHO-GMP certification, and 7 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Linezolid sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and intermediates. Notable firms include A.R. Life Sciences, which manufactures APIs and intermediates adhering to Good Manufacturing Practices (GMP) and holds ISO 9001:2015 certification. Additionally, Hyderabad Pharma City is an ambitious project aiming to create the world's largest integrated pharmaceutical hub, further solidifying the city's position in the industry.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations and biogenerics manufacturing. Vadodara, in particular, is home to Alembic Pharmaceuticals, an Indian multinational company specializing in formulations for therapeutic areas such as cardiology, dermatology, and infectious diseases. The region's focus on formulations complements Hyderabad's API production, creating a comprehensive pharmaceutical supply chain.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. Mumbai, being a major port city, facilitates the export of pharmaceuticals to global markets. Companies like Formel Labs, with facilities in Mumbai and Hyderabad, leverage this strategic location to ensure timely delivery of high-quality medicines. The region's robust infrastructure and proximity to international shipping routes make it an ideal hub for pharmaceutical exports.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives. This area attracts numerous pharmaceutical companies seeking cost-effective production solutions. The presence of WHO-GMP-certified manufacturing units and a skilled workforce further enhances its appeal as a manufacturing hub.
5Sourcing Recommendations
- Diversify Supplier Base: While MACLEODS PHARMACEUTICALS LTD leads in Linezolid exports, consider engaging with other top exporters like ALKEM LABORATORIES LIMITED and LUPIN LIMITED to mitigate supply chain risks.
- Leverage Regional Strengths: Utilize Hyderabad's expertise in API production and Ahmedabad-Vadodara's proficiency in formulations to optimize the supply chain for Linezolid.
- Optimize Export Logistics: Capitalize on the Mumbai-Thane-Raigad region's infrastructure to streamline export processes and reduce lead times for international shipments.
- Explore Cost-Effective Manufacturing: Assess the Baddi-Nalagarh region for potential manufacturing partnerships, taking advantage of tax incentives and established pharmaceutical facilities.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Linezolid exporters from India
LUPIN LIMITED — Lupin acquires two brands from Sanofi in Europe and Canada
Lupin's European subsidiary, Lupin Atlantis Holdings SA, completed the acquisition of Aarane™ in Germany and Nalcrom™ in Canada and the Netherlands from Sanofi. This acquisition aims to enhance Lupin's respiratory business in Germany and expand its specialty portfolio. - IMPACT: This acquisition is not directly related to Linezolid; however, it strengthens Lupin's overall market presence, potentially influencing its export capabilities.
Impact: This acquisition is not directly related to Linezolid; however, it strengthens Lupin's overall market presence, potentially influencing its export capabilities.
LUPIN LIMITED — Lupin Healthcare acquires Renascience Pharma Limited in the UK
Lupin Healthcare (UK) Limited, a wholly owned subsidiary of Lupin Limited, acquired UK-based Renascience Pharma Limited, the sole supplier of four specialty branded products in the UK. This acquisition expands Lupin's branded specialty portfolio in the UK and strengthens its supply offerings to the NHS across infectious disease, ENT, and cardiology/renal indications. - IMPACT: While this acquisition focuses on the UK market, it may enhance Lupin's global distribution network, indirectly affecting Linezolid exports.
Impact: While this acquisition focuses on the UK market, it may enhance Lupin's global distribution network, indirectly affecting Linezolid exports.
ANNORA PHARMA PRIVATE LIMITED — Annora Pharma receives FDA approval for generic Prezista
Annora Pharma received FDA approval for its Abbreviated New Drug Application (ANDA) for Darunavir, the generic version of Prezista, indicating compliance with regulatory standards for generic drug manufacturing. - IMPACT: This regulatory approval may bolster Annora Pharma's credibility and capacity in the pharmaceutical market, potentially influencing its Linezolid export activities.
Impact: This regulatory approval may bolster Annora Pharma's credibility and capacity in the pharmaceutical market, potentially influencing its Linezolid export activities.
Common Questions — Linezolid Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which linezolid supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MACLEODS PHARMACEUTICALS LTD leads with 73 recorded shipments worth $9.4M. ALKEM LABORATORIES LIMITED (85 shipments) and LUPIN LIMITED (46 shipments) are also established high-volume exporters.
Q How many linezolid manufacturers are there in India?
India has 234 active linezolid exporters with a combined export market of $37.5M across 1,427 shipments to 104 countries. The top 5 suppliers hold 68.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for linezolid from India?
Average FOB unit price: $9.51 per unit, ranging from $0.00 to $3369.86. Average shipment value: $26.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 234 verified Indian exporters of Linezolid ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,427 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 104 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,427 Verified Shipments
234 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists